Centerra Gold (NYSE:CGAU) 주식

Centerra Gold

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

Macro,View,Of,Stacks,Of,Gold,Bars

Analyst Color

Government

Large Cap

Macro Economic Events

Regulations

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Commodities

Econ #s

Economics

Federal Reserve

ETFs

$BTC

AAAU

CGAU

Market Vectors ETF Trust Market Vectors Gold Miners

GLDM

GOLD

PAAS

RGLD

SSRM

TFPM

월요일(21일) 금 가격이 사상 최고치로 급등했다. 금은 월요일 오전 11시 20분(동부표준시 기준) 온스당 2.5% 상승한 3,410달러로 상승했다. 이는 미국 금융자산에 대한 불신과 인플레이션 우려로 인해 2010년대 초 글로벌 부채 위기 이후 볼 수 없었던 안전자산으로의 도피가 이어지는 것을 의미한다.

금 가격 사상 최고치, 2011년 이후 가장 강력한 2개월 랠리···엄청난 금 ETF 매수세도 주목

Gold.goldbar.goldnugget.shutterstock

Equities

News

Analyst Ratings

Trading Ideas

금 가격은 그의 장기 목표가인 온스당 3,000달러를 넘어섰으며, 투자 수요가 10% 증가하면 3,500달러까지 상승할 가능성이 있다고 전망했다.

금 랠리, 중앙은행 매입 및 중국의 배분으로 모멘텀 얻을 수 있어 - BofA

Centerra Gold Inc

Jim Cramer believes that a consistent flow of trade agreements is crucial to bolstering market confidence and allaying fears of both recession and a surge in inflation.
What Happened: In a recent post on X, Cramer asserted that a &#8220;steady drip of trade deals&#8221; might be the key ingredient to sustain the current market momentum, particularly given the limited number of institutional investors holding bullish positions.
Cramer&#8217;s commentary underscores the market&#8217;s sensitivity to global trade dynamics and their potential impact on economic stability and price levels. The implication is that positive developments on the trade front could provide the necessary reassurance for investors, outweighing prevailing concerns about a potential economic downturn and escalating inflation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bulls, right now, want nothing but a steady drip of trade deals that will make people more confident that we won&#39;t have a recession and inflation won&#39;t spike. That might just be enough to keep things going given how few institutional bulls there are
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1922199711055806937?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In a subsequent post, Cramer also took aim at prominent bearish voices within the billionaire investor class. While not naming specific individuals in these recent posts, he emphasized the significant influence these figures wield and called for a change in their rhetoric. &#8220;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Last night i simply had to call out still one more bearish billionaire. I will tell you one thing, the words that are used by the billionaire class must change. They must learn their power for mayhem
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1922199974479008140?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Cramer&#8217;s perspective suggests a delicate balancing act for the market. While positive trade developments could act as a vital catalyst for bullish sentiment and potentially ward off recessionary pressures, the pronouncements of influential bearish investors could introduce volatility and undermine confidence.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45367206/sp-500-rallies-over-3-on-us-china-90-day-tariff-truce-but-experts-warn-it-doesnt-guarantee-a-complete-resolution-of-the-trade-war" target="_blank" rel="noreferrer noopener">S&amp;P 500 Rallies Over 3% On US-China 90-Day Tariff Truce, But Experts Warn It ‘Doesn't Guarantee A Complete Resolution Of The Trade War'</a>
Why It Matters: U.S. and China agreed on Monday to <a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">temporarily reduce reciprocal tariffs </a>on each other's goods for 90 days, marking a considerable easing of trade tensions. 
The recent tariff reductions between the <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">U.S. and China</a> echo a similar agreement reached with the U.K. last week, fueling optimism for a revival in global commerce and economic growth. 
However, Cramer&#8217;s call for steady progress on trade deals is vital, as the temporary nature of this 90-day deal with China doesn&#8217;t give a long-term solution.
Despite the initial positive action following the announcement, John Murillo, the chief dealing officer at B2BROKER, <a href="https://www.benzinga.com/government/regulations/25/05/45367206/sp-500-rallies-over-3-on-us-china-90-day-tariff-truce-but-experts-warn-it-doesnt-guarantee-a-complete-resolution-of-the-trade-war">emphasized</a>, "Now, while the 90-day pause is a big step towards easing tensions, it&#8217;s crucial to remember that it doesn&#8217;t guarantee a complete resolution of the trade war." 
Price Action: While the stocks rejoiced at the U.S.-China trade development on Monday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Tuesday. The SPY was down 0.22% to $581.70, while the QQQ declined 0.15% to $507.10, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data. The S&amp;P 500 futures were also trading lower on Tuesday morning.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45371290/chamath-palihapitiya-questions-ai-funding-after-swedish-bnpl-firm-klarna-rolls-back-ai-bets-startups-could-pivot-">Chamath Palihapitiya Says Swedish Fintech Company Klarna Scaling Back AI Support Is A Red Flag For Industry: Startups Could &#8216;Pivot To Simply Use AI For Narrow Use Cases&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock

Macro Notification

Market Summary

Futures

Markets

General

Jim Cramer Says Bulls Need 'Steady Drip Of Trade Deals' To Assure Market About Recession And Inflation As S&P 500 Futures Fall After Big Rally

AFMD

Trading Halt: Halted at 8:25:00 a.m. ET - Trading Halt: Halt News Pending

Baird analyst Joel Beatty upgrades argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) from Neutral to Outperform and maintains the price target from $680 to $680.

Upgrades

Price Target

ARGX

Baird Upgrades argenx to Outperform, Maintains Price Target to $680

Earnings

Earnings Beats

Earnings Misses

HUMA

UPDATE: Humacyte Q1 Adj. EPS $(0.10) Beats $(0.19) Estimate, Sales $517.00K Miss $760.33K Estimate

Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) reported quarterly earnings of $0.07 per share. This is a 16.67 percent increase over earnings of $0.06 per share from the same period last year. The company reported $778.03 thousand in sales this quarter. This is a 6.56 percent decrease over sales of $832.67 thousand the same period last year.

MCVT

Mill City Ventures III Q1 GAAP EPS $0.07 Up From $0.06 YoY, Sales $778.03K Down From $832.67K YoY

Baird analyst Mircea Dobre upgrades Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) from Neutral to Outperform and raises the price target from $309 to $395.

Baird Upgrades Caterpillar to Outperform, Raises Price Target to $395

LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) reported quarterly earnings of $0.01 per share. This is a 105.56 percent increase over losses of $(0.18) per share from the same period last year. The company reported $47.02 million in sales this quarter. This is a 33.93 percent decrease over sales of $71.17 million the same period last year.

LITB

LightInTheBox Holding Q1 EPS $0.01 Up From $(0.18) YoY, Sales $47.02M Down From $71.17M YoY

As of May 13, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Crown Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>)</h3>
<ul class="wp-block-list">
<li>On May 12, Crown Holdings reported that it has priced an offering of $700 million aggregate principal amount of 5.875% senior unsecured notes due 2033. The company's stock jumped around 14% over the past month and has a 52-week high of $99.12.</li>
<li>RSI Value: 72.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CCK Price Action: Shares of Crown Holdings gained 0.8% to close at $97.78 on Monday.</li>
<li>Edge Stock Ratings: 78.55 Momentum score with Value at 29.80. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/cck"><img loading="lazy" decoding="async" width="482" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043838/image-137.png" alt="" class="wp-image-913115" style="width:390px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043838/image-137.png 482w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043838/image-137-300x107.png 300w" sizes="(max-width: 482px) 100vw, 482px" /></a></figure>
<h3 class="wp-block-heading">Celanese Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul class="wp-block-list">
<li>On May 5, Celanese posted better-than-expected results for its first quarter. "Our end-markets in the first quarter exhibited dynamics similar to the fourth quarter, and demand in our businesses developed mostly as we expected," said Scott Richardson, president and chief executive officer. "While tariffs are a constant topic, we saw no direct impact in the first quarter. No matter how the demand environment develops over the remainder of the year, our mission is unchanged." The company's stock gained around 39% over the past month and <a href="https://www.benzinga.com/quote/CE">has a 52-week high</a> of $161.94.</li>
<li>RSI Value: 70.7</li>
<li>CE Price Action: Shares of Celanese gained 6.5% to close at $54.53 on Monday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45368490/under-armour-cyberark-software-and-3-stocks-to-watch-heading-into-tuesday">Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Top 2 Materials Stocks That May Keep You Up At Night In May

Baird analyst Mircea Dobre upgrades Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) from Neutral to Outperform and raises the price target from $48 to $66.

Baird Upgrades Terex to Outperform, Raises Price Target to $66

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday.
Shares of 3D Systems Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) fell sharply in today's pre-market trading after the company posted <a href="https://www.benzinga.com/quote/DDD/earnings">weaker-than-expected quarterly results.</a>
3D Systems reported quarterly losses of 21 cents per share which missed the analyst consensus estimate of losses of 14 cents per share. The company reported quarterly sales of $94.54 million which missed the analyst consensus estimate of $99.46 million.
3D Systems shares dipped 20.7% to $2.02 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Kearny Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) shares dipped 23.5% to $5.00 in pre-market trading after gaining 3% on Monday.</li>
<li>Global IBO Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIBO#NASDAQ">GIBO</a>) declined 18.8% to $4.22 in pre-market trading after dipping over 25% on Monday.</li>
<li>Kindly MD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) dipped 18.2% to $11.15 in pre-market trading. KindlyMD shares jumped 251% on Monday after the company announced a merger agreement with Nakamoto Holdings to start a Bitcoin treasury strategy.</li>
<li>Heritage Commerce Corp (NASDA: HTBK) declined 15.4% to $8.00 in pre-market trading.</li>
<li>Rigetti Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) fell 12.1% to $10.15 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>Exodus Movement, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#NYSE">EXOD</a>) fell 11.1% to $48.25 in pre-market trading following first-quarter results.</li>
<li>NetClass Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) dipped 11% to $25.80 in pre-market trading.</li>
<li>indie Semiconductor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) declined 11% to $2.35 in pre-market trading after the company reported worse-than-expected quarterly sales results.</li>
<li>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) fell 9.1% to $344.44 in pre-market trading. The company announced the appointment of Stephen Hemsley as CEO.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) declined 8.6% to $6.34 in pre-market trading following weak quarterly results.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45368490/under-armour-cyberark-software-and-3-stocks-to-watch-heading-into-tuesday">Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Movers

EXOD

GIBO

HTBK

INDI

KDLY

KRNY

NTCL

RGTI

3D Systems, Rigetti Computing, UnitedHealth Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Buy and maintains $66 price target.

Reiteration

MLTX

Needham Reiterates Buy on MoonLake, Maintains $66 Price Target

Rosenblatt analyst Catharine Trebnick maintains Five9 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) with a Buy and maintains $36 price target.

FIVN

Rosenblatt Maintains Buy on Five9, Maintains $36 Price Target

Bayer (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BAYRY#OTC">BAYRY</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.38 by 71.05 percent. This is a 15.58 percent decrease over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $14.45 billion which beat the analyst consensus estimate of $13.39 billion by 7.89 percent. This is a 3.36 percent decrease over sales of $14.95 billion the same period last year.

BAYRY

Bayer Q1 Adj. EPS $0.65 Beats $0.38 Estimate, Sales $14.45B Beat $13.39B Estimate

ITOS

Trading Halt: Halt status updated at 8:20:00 AM ET: Quotation Resumption: News and Resumption Times

Cycurion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, announces that it has been awarded a significant contract renewal by a major state-level public higher education group. Under this renewed agreement, Cycurion will deliver comprehensive cybersecurity services to member universities and colleges within the group, ensuring they are equipped to defend their education-focused operations and digital assets against the ever-evolving landscape of cyber threats. The renewal, valued at $33 million over the five-year term, extends Cycurion's partnership through November 2030.

CYCU

Cycurion Announces $33M Contract Renewal To Deliver Comprehensive Cybersecurity Services To State-Level Public Higher Education Institutions

Biotech

ONMD

OneMedNet Adopts Expanded Capabilities Within Datavant Connect Platform To Accelerate Healthcare Data Discovery, Analytics, And Partner Assessment Processes

The MoU builds on G42's growing ecosystem as it accelerates its efforts to scale AI infrastructure and innovation
ABU DHABI, UAE, May 13, 2025 /PRNewswire/ --&nbsp;G42, the UAE-based global technology group, today announced the signing of a Memorandum of Understanding (MoU) with Cisco, the global leader in networking and security, laying the groundwork for a strategic collaboration aimed at advancing artificial intelligence (AI) innovation and infrastructure development across public and private sectors.
The agreement was presented to His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, by Peng Xiao, Group Chief Executive Officer of G42, and Chuck Robbins, Chair and Chief Executive Officer of Cisco.

CISO

G42 And Cisco Sign Strategic MOU To Extend Partnership To Drive AI Innovation And Infrastructure Development

Rosenblatt analyst Catharine Trebnick maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and maintains $445 price target.

CYBR

Rosenblatt Maintains Buy on CyberArk Software, Maintains $445 Price Target

&nbsp;IT Tech Packaging Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the pricing of a public offering of 6,899,500 shares of its common stock at a price to the public of $0.20 per share. The gross proceeds from the offering to IT Tech Packaging are expected to be approximately $1.4 million, before deducting offering fees and expenses. The offering is expected to close on May 14, 2025, subject to customary closing conditions.
Maxim Group LLC is acting as the sole placement agent for the offering.
IT Tech Packaging intends to use the net proceeds of this offering for working capital and other general corporate purposes.

Offerings

IT Tech Packaging Announces Pricing Of $1.4M Public Offering Of 6,899,500 Shares Of Its Common Stock At A Price To The Public Of $0.20 Per Share

NeuroOne Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million.

Guidance

NMTC

NeuroOne Medical Tech Affirms FY2025 Product Revenue Guidance of $8.00M-$10.00M

Press Releases

Centerra Gold Files Annual Report on Form 40-F

Centerra Gold Provides Notice of First Quarter 2025 Results and Conference Call and Details for Annual Meeting of Shareholders

Kestrel Partner Centerra to Continue Exploration at Kestrel's QCM Gold Property

Azimut Arranges Strategic Investment by Centerra Gold

Centerra Gold Announces Updated Mineral Resources at Kemess; Advancing Studies on the Project

Centerra Gold Reports First Quarter 2025 Results; Approved up to $75 Million to Repurchase Shares in 2025; Announces Updated Mineral Resource at Kemess and Advancing Studies on the Project

Dividends

Centerra Gold Announces Quarterly Dividend of C$0.07 per Common Share

Centerra Gold Announces Results of 2025 Annual Meeting of Shareholders

Small Cap

Opinion

Gold's Return to $3,400 Spurs Sector Gains Amid $4,000 Forecasts

Grid Battery Metals Provides a CEO Update

EVKRF

KSTBF

LVGLF

NILIF

OMGGF

TSX:CG

TSX:GAU

TSX:IAU

TSXV:AZM

TSXV:CELL

TSXV:KGC

TSXV:LVG

TSXV:NILI

TSXV:NWST

TSXV:OMG

Scotiabank

CIBC

Raymond James

TD Securities

Comments

Centerra Gold

뉴스

파트너 / 기고자

벤징가 글로벌